Search Results - "MORIOKA, Tomoaki"

Refine Results
  1. 1

    Myostatin: The Missing Link between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease? by Morioka, Tomoaki

    Published in Journal of Atherosclerosis and Thrombosis (01-10-2020)
    “…[See article vol.27 : 1039-1052] Chronic kidney disease (CKD) is characterized by a high prevalence of cardiovascular disease and, more importantly, a high…”
    Get full text
    Journal Article
  2. 2

    The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification by Shioi, Atsushi, Morioka, Tomoaki, Shoji, Tetsuo, Emoto, Masanori

    Published in Nutrients (23-02-2020)
    “…Vitamin K is a fat-soluble vitamin that is indispensable for the activation of vitamin K-dependent proteins (VKDPs) and may be implicated in cardiovascular…”
    Get full text
    Journal Article
  3. 3
  4. 4

    New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination by Yano, Masahiro, Morioka, Tomoaki, Natsuki, Yuka, Sasaki, Keyaki, Kakutani, Yoshinori, Ochi, Akinobu, Yamazaki, Yuko, Shoji, Tetsuo, Emoto, Masanori

    Published in Internal Medicine (15-04-2022)
    “…During the ongoing coronavirus disease 2019 (COVID-19) pandemic, it is critical to ensure the safety of COVID-19 vaccines. We herein report a 51-year-old…”
    Get full text
    Journal Article
  5. 5

    Is Stiffness Parameter β Useful for the Evaluation of Atherosclerosis?~ Its Clinical Implications, Limitations, and Future Perspectives by Morioka, Tomoaki, Mori, Katsuhito, Emoto, Masanori

    Published in Journal of Atherosclerosis and Thrombosis (01-05-2021)
    “…Atherosclerosis comprises two components, atherosis and sclerosis, characterized by morphological wall thickening and functional stiffening, respectively, of…”
    Get full text
    Journal Article
  6. 6

    New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report by Sasaki, Keyaki, Morioka, Tomoaki, Okada, Natsumi, Natsuki, Yuka, Kakutani, Yoshinori, Ochi, Akinobu, Yamazaki, Yuko, Shoji, Tetsuo, Ohmura, Takashi, Emoto, Masanori

    Published in Journal of diabetes investigation (01-07-2022)
    “…Fulminant type 1 diabetes is characterized by a rapid progression of insulin deficiency triggered by viral infection. Here, we report a case of a 45‐year‐old…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial by Iseki, Kunitoshi, Kabata, Daijiro, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori, Mori, Katsuhito, Morioka, Tomoaki, Nakatani, Shinya, Shintani, Ayumi

    Published in PloS one (07-09-2022)
    “…The selection of dialysate calcium concentration (D-Ca) is still controversial among chronic hemodialysis (HD) regimens. We examined the trajectories of CKD…”
    Get full text
    Journal Article
  9. 9

    Associations of Serum Insulin-Like Growth Factor 1 with New Cardiovascular Events and Subsequent Death in Hemodialysis Patients: The DREAM Cohort by Nakaya, Rino, Shoji, Tetsuo, Nagata, Yuki, Nakatani, Shinya, Mori, Katsuhito, Morioka, Tomoaki, Tsujimoto, Yoshihiro, Emoto, Masanori

    Published in Journal of Atherosclerosis and Thrombosis (01-08-2022)
    “…Aim: Patients with chronic kidney disease (CKD) have elevated risk of death from cardiovascular disease (CVD). A low serum insulin-like growth factor 1 (IGF-1)…”
    Get full text
    Journal Article
  10. 10

    Improvement in the mobility of a patient with fibroblast growth factor 23-related hypophosphatemic osteomalacia and decompensated liver cirrhosis in response to burosumab: a case report by Toi, Norikazu, Imanishi, Yasuo, Nagata, Yuki, Kurajoh, Masafumi, Morioka, Tomoaki, Shoji, Tetsuo, Shinto, Yoshitaka, Emoto, Masanori

    Published in Endocrine Journal (01-01-2023)
    “…Acquired fibroblast growth factor (FGF) 23-related hypophosphatemic osteomalacia is characterized clinically by muscle weakness, bone pain, and fractures. Its…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan by Kurajoh, Masafumi, Akari, Seigo, Nakamura, Takashi, Ihara, Yasutaka, Imai, Takumi, Morioka, Tomoaki, Emoto, Masanori

    Published in Frontiers in pharmacology (2024)
    “…Urate-lowering drugs (ULDs) have been approved for treatment of asymptomatic hyperuricemia and gout in Japan. Although serum urate levels and rates of gout…”
    Get full text
    Journal Article
  13. 13

    Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves’ disease: a case report by Shimmaru, Kento, Inami, Mitsuhiro, Hamaoka, Aya, Fujiwara, Noriko, Morioka, Tomoaki, Emoto, Masanori, Kamei, Nozomu

    Published in Endocrine Journal (01-01-2023)
    “…Biotin is a water-soluble vitamin that acts as a cofactor for carboxylase, and is often used as a component in several immunoassays. We present a case of a…”
    Get full text
    Journal Article
  14. 14

    Effects of fetuin-A-containing calciprotein particles on posttranslational modifications of fetuin-A in HepG2 cells by Uedono, Hideki, Mori, Katsuhito, Ochi, Akinobu, Nakatani, Shinya, Miki, Yuya, Tsuda, Akihiro, Morioka, Tomoaki, Nagata, Yuki, Imanishi, Yasuo, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori

    Published in Scientific reports (05-04-2021)
    “…Fetuin-A is an inhibitor of ectopic calcification that is expressed mainly in hepatocytes and is secreted into the circulation after posttranslational…”
    Get full text
    Journal Article
  15. 15

    Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation by Miki, Yuya, Morioka, Tomoaki, Shioi, Atsushi, Fujimoto, Kenta, Sakura, Takeshi, Uedono, Hideki, Kakutani, Yoshinori, Ochi, Akinobu, Mori, Katsuhito, Shoji, Tetsuo, Emoto, Masanori, Inaba, Masaaki

    “…Oncostatin M (OSM) is a cytokine of the interleukin-6 family and plays a role in various disorders such as cancer and inflammatory diseases, which are often…”
    Get full text
    Journal Article
  16. 16

    Inter-Arm Blood Pressure Difference in Diabetes Mellitus and Its Preferential Association with Peripheral Artery Disease by Miyashima, Masako, Shoji, Tetsuo, Kakutani, Yoshinori, Yamazaki, Yuko, Ochi, Akinobu, Morioka, Tomoaki, Shinohara-Mitsuki, Kayo, Fukumoto, Shinya, Shioi, Atsushi, Inaba, Masaaki, Emoto, Masanori

    Published in Journal of Atherosclerosis and Thrombosis (01-08-2020)
    “…Aim: Inter-arm blood pressure difference (IAD) is known to be associated with a composite of cardiovascular disease (CVD) and with CVD risk factors. However,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non‐severe coronavirus disease 2019 by Numaguchi, Ryutaro, Kurajoh, Masafumi, Hiura, Yoshikazu, Imai, Takumi, Morioka, Tomoaki, Saito, Mika, Shiraishi, Satoshi, Emoto, Masanori, Nishiguchi, Yukio

    Published in Journal of diabetes investigation (01-10-2022)
    “…Aims/Introduction Poor glycemic control is known to be associated with severe infection development. This retrospective observational study examined whether…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes by Natsuki, Yuka, Morioka, Tomoaki, Kakutani, Yoshinori, Yamazaki, Yuko, Ochi, Akinobu, Kurajoh, Masafumi, Mori, Katsuhito, Imanishi, Yasuo, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori

    Published in Journal of Atherosclerosis and Thrombosis (01-12-2023)
    “…Aim: Increased level of serum fibroblast growth factor 23 (FGF23) is a hallmark of abnormal phosphate metabolism in patients with chronic kidney disease (CKD)…”
    Get full text
    Journal Article